WASHINGTON — The U.S. administration has added dozens of new prescription drugs to the TrumpRx.gov platform, expanding access to lower-cost generic medications as part of ongoing efforts to increase price transparency, officials said.
The expansion, announced in recent days, brings the total number of medications available on the direct-to-consumer site to more than 800, according to administration statements. It follows earlier additions of over 600 generics in May 2026.
TrumpRx.gov allows Americans to compare competitive cash prices for medications without insurance intermediaries. The platform features common drugs for conditions such as high cholesterol, high blood pressure, diabetes and blood thinning.
"I am pleased to announce that TrumpRx.gov is adding another 160 Prescription Drugs, at highly discounted prices, for a new total of over 800 of the most commonly-used Prescription Drugs," President Donald Trump stated on Truth Social.
The initiative aims to provide patients with clearer options to compare prices against insurance co-pays. Officials have highlighted partnerships that enable competitive pricing and features like connecting users to local pharmacies or home delivery.
The platform was launched earlier in the administration to address high prescription drug costs. Supporters say it empowers consumers with information, while critics have raised questions about its reach and impact on broader insurance systems. Details on specific savings claims remain subject to verification through user reports and independent analysis.
Health and Human Services officials noted that the additions build on guidance issued earlier in 2026 clarifying pathways for manufacturers to offer lower-cost options directly to patients, including those in Medicare and Medicaid, under certain conditions.
As of June 7, 2026, the site continues to expand its catalog. No immediate information was available on further planned additions or usage statistics beyond administration reports. Patients are encouraged to consult healthcare providers when considering medication changes.
